Search Results - "Al Naber, J."

Designing Trials of Disease Modifying Agents for Early and Preclinical Alzheimer’s Disease Intervention: What Evidence is Meaningful to Patients, Providers, and Payers? by Messner, Donna A., Rabins, P., Downing, A. C., Irizarry, M., Foster, N. L., Al Naber, J., Dabbous, O., Fillit, H., Gabler, S., Krakauer, R., Lotz, D., Payzant, E., Schneider, L., Tyrone, J., Van Amerongen, D., Wuest, D.

“…Background Drug development for disease modifying agents in Alzheimer’s disease (AD) is focused increasingly on targeting underlying pathology in very early…”
Get full text

P226 AMPLIFYING PATIENT VOICES IN RESEARCH: PATIENT ENGAGEMENT IN CORE OUTCOME SET DEVELOPMENT FOR ASTHMA TRIALS by Chang, H., Tran, A., Al Naber, J., Tambor, E., Moloney, R.

Get full text

Core Outcome Sets in Clinical Research: What are They and How Can they Help Decision Makers? by Moloney, RM, Messner, DA, Al Naber, J, Tunis, SR

Get full text

PCP22 - Core Outcome Sets in Clinical Research: What are They and How Can they Help Decision Makers? by Moloney, RM, Messner, DA, Al Naber, J, Tunis, SR

Get full text

PRM10 - First Steps in Choosing Appropriate Instruments/Measurements for a Core Outcome Set: An Example from Corehem by Tunis, SR, Skinner, MW, Clearfield, E, Messner, DA, Al Naber, J, Iorio, A

Get full text

First Steps in Choosing Appropriate Instruments/Measurements for a Core Outcome Set: An Example from Corehem by Tunis, SR, Skinner, MW, Clearfield, E, Messner, DA, Al Naber, J, Iorio, A

Get full text

CORE CLINICAL DATA ELEMENTS FOR CANCER GENOMIC REPOSITORIES: A MULTI-STAKEHOLDER CONSENSUS by Conley, RB, Dickson, DJ, Zenklusen, JC, Al Naber, J, Messner, DA

“…OBJECTIVES: A 2016 report from the Institute of Medicine concluded that one of the barriers to achieving the full potential of precision medicine was the…”
Get full text

PRM176 - Developing Best Practices For Managing Treatment Switching In The Design, Conduct, Analysis, And Reporting Of Oncology Drug Clinical Trials by Conley, RB, Al Naber, J, Messner, DA, Henshall, C, Huang, C, Rosner, GL

Get full text

Developing Best Practices For Managing Treatment Switching In The Design, Conduct, Analysis, And Reporting Of Oncology Drug Clinical Trials by Conley, RB, Al Naber, J, Messner, DA, Henshall, C, Huang, C, Rosner, GL

Get full text